|
1
|
S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance.
|
J Biol Chem
|
2005
|
1.96
|
|
2
|
Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.
|
Int J Cancer
|
2005
|
1.39
|
|
3
|
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance.
|
Am J Physiol Endocrinol Metab
|
2002
|
1.12
|
|
4
|
Phyllodes tumor of the breast: correlation between MR findings and histologic grade.
|
Radiology
|
2006
|
1.08
|
|
5
|
Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
|
Hepatogastroenterology
|
2008
|
1.07
|
|
6
|
Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
|
Eur J Radiol
|
2009
|
1.00
|
|
7
|
Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer.
|
Ann Surg Oncol
|
2011
|
0.99
|
|
8
|
Vimentin as a poor prognostic factor for triple-negative breast cancer.
|
J Cancer Res Clin Oncol
|
2013
|
0.96
|
|
9
|
Diagnostic performance in differentiation of breast lesion on digital mammograms: comparison among hard-copy film, 3-megapixel LCD monitor, and 5-megapixel LCD monitor.
|
Clin Imaging
|
2011
|
0.93
|
|
10
|
Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer.
|
Magn Reson Med Sci
|
2013
|
0.93
|
|
11
|
Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging.
|
Eur Radiol
|
2010
|
0.91
|
|
12
|
Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study.
|
Breast Cancer
|
2013
|
0.91
|
|
13
|
Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications.
|
Anticancer Res
|
2009
|
0.90
|
|
14
|
MR imaging features of pure mucinous carcinoma of the breast.
|
Eur J Radiol
|
2006
|
0.89
|
|
15
|
Genetic mutual relationship between PTEN and p53 in gastric cancer.
|
Cancer Lett
|
2005
|
0.87
|
|
16
|
Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.
|
Oncol Rep
|
2006
|
0.87
|
|
17
|
Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer.
|
Clin Imaging
|
2012
|
0.86
|
|
18
|
Circumscribed mass lesions on mammography: dynamic contrast-enhanced MR imaging to differentiate malignancy and benignancy.
|
Magn Reson Med Sci
|
2008
|
0.86
|
|
19
|
HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer.
|
Int J Cancer
|
2010
|
0.86
|
|
20
|
Technical improvement of total pharyngo-laryngo-esophagectomy for esophageal cancer and head and neck cancer.
|
Ann Surg Oncol
|
2014
|
0.85
|
|
21
|
Impact of loss of heterozygosity of encoding phosphate and tensin homolog on the prognosis of gastric cancer.
|
J Gastroenterol Hepatol
|
2006
|
0.84
|
|
22
|
Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer.
|
Breast Cancer
|
2014
|
0.84
|
|
23
|
Prediction of recurrence after curative resection of gastric carcinoma invading the muscularis propria: a multivariate analysis.
|
Gastric Cancer
|
2000
|
0.83
|
|
24
|
FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
|
Ann Surg Oncol
|
2012
|
0.83
|
|
25
|
Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
|
Mol Cancer Res
|
2013
|
0.82
|
|
26
|
Gender differences in prognosis after esophagectomy for esophageal cancer.
|
Surg Today
|
2013
|
0.82
|
|
27
|
Topochemical synthesis and catalysis of metal nanoparticles exposed on crystalline cellulose nanofibers.
|
Chem Commun (Camb)
|
2010
|
0.82
|
|
28
|
Advances in esophageal surgery in elderly patients with thoracic esophageal cancer.
|
Anticancer Res
|
2013
|
0.81
|
|
29
|
Clinical significance of micrometastasis in bone marrow of patients with gastric cancer and its relation to angiogenesis.
|
Gastric Cancer
|
1999
|
0.81
|
|
30
|
Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.
|
Ann Surg Oncol
|
2011
|
0.81
|
|
31
|
Predictive factors for anthracycline-based chemotherapy for human breast cancer.
|
Breast Cancer
|
2009
|
0.81
|
|
32
|
Real-time 3-dimensional virtual reality navigation system with open MRI for breast-conserving surgery.
|
J Am Coll Surg
|
2010
|
0.80
|
|
33
|
Detection of disseminated cancer cells in bone marrow of gastric cancer using real time quantitative reverse transcriptase polymerase chain reaction.
|
Cancer Lett
|
2002
|
0.80
|
|
34
|
Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients.
|
Surg Today
|
2013
|
0.79
|
|
35
|
Clinical significance of cytokeratin positive cells in bone marrow of gastric cancer patients.
|
J Cancer Res Clin Oncol
|
2007
|
0.79
|
|
36
|
Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.
|
World J Gastroenterol
|
2009
|
0.79
|
|
37
|
Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in Japan.
|
Surg Today
|
2013
|
0.78
|
|
38
|
[Treatment of gastric cancer: current state and future prospect].
|
Fukuoka Igaku Zasshi
|
2003
|
0.78
|
|
39
|
Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma.
|
Ann Surg Oncol
|
2015
|
0.78
|
|
40
|
Gold nanoparticle-based colorimetric assay for cancer diagnosis.
|
Biosens Bioelectron
|
2009
|
0.78
|
|
41
|
Surgical strategies for esophageal cancer associated with head and neck cancer.
|
Surg Today
|
2013
|
0.77
|
|
42
|
Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma.
|
Hepatogastroenterology
|
2003
|
0.77
|
|
43
|
Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers.
|
J Cancer Res Clin Oncol
|
2007
|
0.77
|
|
44
|
[A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
|
Gan To Kagaku Ryoho
|
2006
|
0.76
|
|
45
|
Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan.
|
Cancer Nurs
|
2015
|
0.76
|
|
46
|
Contribution of BubR1 to oxidative stress-induced aneuploidy in p53-deficient cells.
|
Cancer Med
|
2013
|
0.76
|
|
47
|
The present state and perception of young women with breast cancer towards breast reconstructive surgery.
|
Int J Clin Oncol
|
2014
|
0.76
|
|
48
|
A case of invasive micropapillary carcinoma of the breast involving extensive lymph node metastasis.
|
World J Surg Oncol
|
2014
|
0.75
|
|
49
|
[Departmental review of surgical cases in the last 17 years: Breast neoplasms].
|
Fukuoka Igaku Zasshi
|
2002
|
0.75
|
|
50
|
[Molecular target therapy for colonic neoplasms].
|
Nihon Naika Gakkai Zasshi
|
2007
|
0.75
|
|
51
|
[The Molecular Aspect of the Antitumor Effect of Oxaliplatin in Combination with 5-FU].
|
Gan To Kagaku Ryoho
|
2016
|
0.75
|
|
52
|
Prediction of survival from first recurrence of breast carcinoma in Japanese women.
|
Breast
|
2005
|
0.75
|
|
53
|
[Evolving 5-Fluorouracil Therapy to Achieve Enhanced Efficacy-Past and Current Efforts of Researchers].
|
Gan To Kagaku Ryoho
|
2016
|
0.75
|
|
54
|
[Development of a molecular target therapy on the basis of global gene analyses of gastrointestinal carcinoma].
|
Fukuoka Igaku Zasshi
|
2006
|
0.75
|
|
55
|
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers.
|
Cancer Lett
|
2008
|
0.75
|
|
56
|
Luteinizing hormone-releasing hormone agonist plus an aromatase inhibitor as second-line endocrine therapy in premenopausal females with hormone receptor-positive metastatic breast cancer.
|
Surg Today
|
2013
|
0.75
|
|
57
|
[Departmental review of surgical cases in the last 17 years: The Cancer Research Center].
|
Fukuoka Igaku Zasshi
|
2002
|
0.75
|
|
58
|
[Chemotherapy for gastric cancer].
|
Gan To Kagaku Ryoho
|
2003
|
0.75
|
|
59
|
[Fanconi anemia and genomic instability].
|
Fukuoka Igaku Zasshi
|
2008
|
0.75
|
|
60
|
[Antitumor Molecular Mechanism of Trifluridine and Tipiracil Hydrochloride(TAS- 102: TFTD)].
|
Gan To Kagaku Ryoho
|
2016
|
0.75
|
|
61
|
Correlation with bone metastasis and high expression of CK 19 mRNA measured by quantitative RT-PCR in the bone marrow of breast cancer patients.
|
Breast J
|
2003
|
0.75
|